Genentech's Asthma Product, Xolair, Receives FDA Panel Nod May 16, 2003 By Kim Coghill An FDA advisory panel said Xolair appears to work well enough in moderate to severe allergic asthmatic patients to win regulatory approval. (BioWorld Today)Read More
